sour reaction initi conserv
guid continu see upsid
net dbt
report organ sale growth yoy report revenu
line w/ our/street est key companion anim
group recur revenu unit grew organ biggest delta vs
model softer refer lab ou outsid us margin
strong gm yoy mix opm yoy
constant currenc basi bottom line ep vs our/street
estim although beat tie higher-than expect
biz perform well one-off item
note part despit competit nois product launch
industri consolid core busi continu impress recur
revenu organ ytd consum growth softwar
growth instrument sale one area weak core busi
quarter soft refer lab result tie specif weather-
relat issu europ heat wave result fewer vet visit ou growth
total refer lab sale low- mid-singl digit vs mid-teen us
expect impact fade go forward
reaction print focus initi guid organ sale
growth fx headwind ep organ guid
line expect believ earn guid regard overli
conserv street look note core constant currenc
basi ep growth still guid yoy fx rel
stock-bas compens account much differ believ neg
stock reaction over-don given see continu runway underli stori
see multipl avenu upsid adjust estim see
sale ep reiter buy rate new po
base price-to-earnings due multipl contract among
high-growth name healthcar
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
lead provid diagnost
inform technolog product servic
pet product anim health water qualiti
milk safeti human point-of-car diagnost
market leader thank rich new
product cycl posit trend companion
anim health market compani look well
posit continu strong growth trajectori
share trade premium peer
compani histor trend believ
premium well-deserv compani long-
term runway continu out-perform
driven new product launch industry-
share trade signific premium broader anim health peer
group histor level howev given mani posit secular product
tailwind compani current enjoy believ premium valuat justifi
po base ep estim in-lin
histor trend observ high growth life scienc diagnost tool compani
broader coverag univers
downsid risk po lower spend vet servic event
econom slowdown slower-than-expect uptak new product ou expans
competit lower-than-expect margin expans weather disrupt currenc
derik de bruin herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
